Details of the Drug
General Information of Drug (ID: DMUILX8)
Drug Name |
N-(2-phenylimidazo[1,2-a]pyridin-3-yl)benzamide
|
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
N-(2-phenylimidazo[1,2-a]pyridin-3-yl)benzamide; CHEMBL379553; 171628-57-2; N-{2-phenylimidazo[1,2-a]pyridin-3-yl}benzamide; AC1LF77Z; Oprea1_830806; MLS001162915; CTK0E4651; DTXSID60353680; MolPort-002-132-975; HMS2842E11; ZINC193750; BDBM50187634; STK367224; AKOS001415177; MCULE-3771425109; SMR000495823; SR-01000196826; N-(2-Phenylimidazo[1,2-a]pyridine-3-yl)benzamide; SR-01000196826-1; Benzamide, N-(2-phenylimidazo[1,2-a]pyridin-3-yl)-
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Drug Type |
Small molecular drug
|
|||||||||||||||||||
Structure |
![]() |
|||||||||||||||||||
3D MOL | 2D MOL | |||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 313.4 | ||||||||||||||||||
Topological Polar Surface Area (xlogp) | 4.6 | |||||||||||||||||||
Rotatable Bond Count (rotbonds) | 3 | |||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | |||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | |||||||||||||||||||
Chemical Identifiers |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||
References